We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Giving Cancer a Deadly Fever

Giving Cancer a Deadly Fever

Giving Cancer a Deadly Fever

Giving Cancer a Deadly Fever

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Giving Cancer a Deadly Fever"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

When combined with other treatments such as radiotherapy or chemotherapy, heat applied directly to tumors helps increase the effectiveness of those types of treatments, and it reduces the necessary dose of chemicals or radiation.

This is where magnetic nanoparticles come in. These balls of iron oxide, just a few tens of nanometers in diameter, heat up when exposed to a powerful magnetic field. Their purpose is to bring heat directly to the tumors. Materials research, performed in part at the NIST Center for Neutron Research (NCNR), revealed magnetic behavior that proved counterintuitive to the scientific team—a finding that will affect which particles are chosen for a particular treatment. 

Choosing the right kind of particles is important because, depending on their structure, they deliver a different dose of heat to the cancer. Some heat up quickly at first, while others require a stronger magnetic field to get going but ultimately deliver more heat. 

“You want to design your nanoparticles for the kind of cancer you’re treating—whether it’s localized or spread through the body,” says NIST’s Cindi Dennis. “The amount of electricity needed to create the field can be 100 kilowatts or more. That costs a lot of money, so we want to help engineer particles that will do the best job.”

Although the magnetic field applied for hyperthermia is 100 to 1,000 times weaker that that typically used for MRI imaging, Dennis explains, it’s an alternating field (the magnetic polarity switches rapidly), which requires a lot more power.

With colleagues at Johns Hopkins University School of Medicine, the University of Manitoba and in industry, the team studied two kinds of iron-oxide nanoparticles, each of which has a different internal structure. In one, iron-oxide crystals are stacked neatly, like bricks in a wall; in the other, the arrangement is more haphazard, like balls in a playpen. While subjecting both types to an alternating magnetic field, the team discovered that the neatly-stacked ones needed a stronger field than expected to heat up, while the haphazard particles got hot more quickly, even when the field was still weak.

It took a trip to the NCNR to figure out why these nanoparticles acted strangely. The neutron experiments showed regions of different sizes and shapes in the particles. Within each region, the so-called magnetic moments are uniform and point in the same direction. But the regions themselves did not align with each other. This unexpected behavior among regions, it turns out, profoundly affects the nanoparticles’ response to a magnetic field.“

"Materials often behave unexpectedly on the nanoscale, and here we have another example of that,” Dennis says. “We expect it will help design better cancer treatments. A localized cancer could be treated with nanoparticles that give out lots of heat right away because the field can be focused on a small region.”